Michael Klichinsky
Impact in
- Oncology top 0.5%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Viral-associated cancers and disorders
- Immunology top 2%
- Immune cells in cancer
- Immunotherapy and Immune Responses
Papers in
- Oncology 27
- CAR-T cell therapy research 24
- Cancer Immunotherapy and Biomarkers 2
- Viral-associated cancers and disorders 2
-
- Immune cells in cancer 4
- Immunotherapy and Immune Responses 2
- Co-authors
- Saar I. Gill (17 shared papers)Nicholas G. Minutolo (1 shared paper)Nicholas R. Anderson (1 shared paper)Carl H. June (14 shared papers)Marco Ruella (15 shared papers)Saad S. Kenderian (15 shared papers)Olga E. Shestova (14 shared papers)D. Christopher Sloas (2 shared papers)
- Journals
- Blood (6 papers)Transplantation and Cellular Therapy (4 papers)Nature Communications (2 papers)Nature Medicine (2 papers)Leukemia (2 papers)
- Partner nations
- United StatesItalyGermany
In The Last Decade
Michael Klichinsky
31 papers receiving 5.1k citations
Michael Klichinsky's Hit Papers
Peers
Comparison fields: 5 of 82
- Oncology 3.1k
- Immunology 1.2k
- Hematology 290
- Genetics 142
- Biomaterials 118
Countries citing papers authored by Michael Klichinsky
This map shows the geographic impact of Michael Klichinsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Klichinsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Klichinsky more than expected).
Fields of papers citing papers by Michael Klichinsky
This network shows the impact of papers produced by Michael Klichinsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Klichinsky. The network helps show where Michael Klichinsky may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Klichinsky, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Human chimeric antigen receptor macrophages for cancer immunotherapy Hit paper breakdown → | 2020 | 1206 |
| 2 | Macrophage-Based Approaches for Cancer Immunotherapy Hit paper breakdown → | 2020 | 566 |
| 3 | Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell Hit paper breakdown → | 2018 | 541 |
| 4 | Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapies Hit paper breakdown → | 2016 | 497 |
| 5 | 2018 | 380 | |
| 6 | 2015 | 374 | |
| 7 | 2012 | 207 | |
| 8 | 2021 | 199 | |
| 9 | 2017 | 173 | |
| 10 | 2016 | 164 | |
| 11 | CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial Hit paper breakdown → | 2025 | 157 |
| 12 | 2015 | 114 | |
| 13 | 2016 | 112 | |
| 14 | 2011 | 110 | |
| 15 | Chimeric antigen receptor macrophages (CAR-M) sensitize HER2+ solid tumors to PD1 blockade in pre-clinical models Hit paper breakdown → | 2025 | 71 |
| 16 | 2022 | 51 | |
| 17 | In vivo chimeric antigen receptor (CAR)-T cell therapy Hit paper breakdown → | 2025 | 47 |
| 18 | 2016 | 37 | |
| 19 | 2017 | 27 | |
| 20 | 2016 | 17 |
About Michael Klichinsky
Michael Klichinsky is a scholar working on Oncology, Immunology, Hematology, Physiology and Hepatology, having authored 32 papers that have together received 5.1k indexed citations. Recurring topics across this work include CAR-T cell therapy research (24 papers), Immune cells in cancer (4 papers), Acute Myeloid Leukemia Research (4 papers), Cancer Immunotherapy and Biomarkers (2 papers), Immunotherapy and Immune Responses (2 papers), Viral-associated cancers and disorders (2 papers), CRISPR and Genetic Engineering (2 papers) and Asthma and respiratory diseases (2 papers). The work is most often cited by research in Oncology (3.1k citations), Immunology (1.2k citations), Hematology (290 citations), Genetics (142 citations) and Biomaterials (118 citations). Michael Klichinsky has collaborated with scholars based in United States, Italy and Germany. Frequent co-authors include Saar I. Gill, Nicholas G. Minutolo, Nicholas R. Anderson, Carl H. June, Marco Ruella, Saad S. Kenderian, Olga E. Shestova, D. Christopher Sloas, Italo Tempera and Paul M. Lieberman. Their work appears in journals such as Blood, Transplantation and Cellular Therapy, Nature Communications, Nature Medicine and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.